Experimental models of endocrine responsive breast cancer: strengths, limitations, and use.

Clarke, Robert; Jones, Brandon C; Sevigny, Catherine M; Hilakivi-Clarke, Leena A; Sengupta, Surojeet

Clarke, Robert; Jones, Brandon C; Sevigny, Catherine M; Hilakivi-Clarke, Leena A; Sengupta, Surojeet.

Afiliação

Clarke R; The Hormel Institute and Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Austin, MN 55912, USA.
Jones BC; Department of Oncology, Georgetown University Medical Center, Washington, DC 20057, USA.
Sevigny CM; Department of Oncology, Georgetown University Medical Center, Washington, DC 20057, USA.
Hilakivi-Clarke LA; The Jackson Laboratory, 600 Main Street, Bar Harbor, ME 04609, USA.
Sengupta S; The Hormel Institute and Department of Biochemistry, Molecular Biology and Biophysics, University of Minnesota, Austin, MN 55912, USA.

Cancer Drug Resist ; 4: 762-783, 2021.

Article em En | MEDLINE | ID: mdl-34532657

Palavras-chave

Breast cancer; PDX; experimental models; study design; xenografts

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancer Drug Resist Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google